首页 > 最新文献

JMIR Diabetes最新文献

英文 中文
A Tailor-Made Mobile App With a Local Cuisine Database for Self-Management of Type 2 Diabetes Mellitus: Randomized Controlled Trial. 一款带有当地美食数据库的定制移动应用程序用于2型糖尿病的自我管理:随机对照试验。
IF 2.6 Q2 Medicine Pub Date : 2025-12-29 DOI: 10.2196/83685
Supasuta Wongdama, Wannaporn Paemueang, Chutintorn Sriphrapradang

Background: There are many mobile apps for diabetes self-management; however, most target Western populations and lack dietary content relevant to Asian contexts. Our mobile app addresses this gap by providing self-care tools and a database of regionally relevant foods.

Objective: This study aimed to evaluate the effectiveness of the app in improving glycemic control and self-care behaviors among outpatients with uncontrolled type 2 diabetes at our hospital.

Methods: We conducted a randomized controlled trial with adults with type 2 diabetes, hemoglobin A1c (HbA1c) of >7%, and access to a smartphone. Participants were randomized to an intervention group (daily use of the Rama Diabetes Care app) or a control group (standard care), with all receiving diabetes self-management education and support. The app includes 6 features, notably a nutritional logging system with a verified database of Thai and commonly consumed foods, including Asian and Western dishes, as well as blood glucose monitoring, exercise and medication tracking, symptom screening, and weight logging. The primary outcome was HbA1c level, and secondary outcomes included fasting plasma glucose (FPG), low-density lipoprotein cholesterol, estimated glomerular filtration rate, BMI, self-care behaviors, and user satisfaction with the app. The study was conducted between November 29, 2023, and October 30, 2024.

Results: A total of 129 participants were randomized (intervention: n=64, 49.6%; control: n=65, 50.4%). Participants in the intervention group were younger (mean age 54.6, SD 14.3 years vs 61.9, SD 12.0 years; P=.002), whereas baseline HbA1c (mean 9.3%, SD 1.96%) and FPG (mean 179.5, SD 5.9 mg/dL) levels were similar between the groups. Over 6 months, the intervention group showed a greater HbA1c reduction than the control group (mean difference -0.24%), but the difference was not statistically significant (P=.13). Among participants aged <65 years, FPG at 6 months was significantly lower in the intervention group (mean difference -29.3 mg/dL; P=.03). App satisfaction was rated as moderate.

Conclusions: The mobile app achieved glycemic control comparable to that achieved through standard care, with significant improvement in FPG among participants younger than 65 years. Tailor-made apps integrating regionally relevant dietary content may support effective self-management in type 2 diabetes and warrant further evaluation in larger, long-term studies.

背景:糖尿病自我管理的手机应用很多;然而,大多数针对西方人群,缺乏与亚洲环境相关的饮食内容。我们的移动应用程序通过提供自我保健工具和区域相关食品数据库来解决这一差距。目的:本研究旨在评价应用app改善我院2型糖尿病门诊患者血糖控制及自我护理行为的效果。方法:我们进行了一项随机对照试验,患者为2型糖尿病患者,血红蛋白A1c (HbA1c)为7%,并使用智能手机。参与者被随机分为干预组(每天使用Rama糖尿病护理应用程序)或对照组(标准治疗),所有参与者都接受糖尿病自我管理教育和支持。该应用程序包括6项功能,其中最引人注目的是一个营养记录系统,该系统拥有经过验证的泰国和常用食物数据库,包括亚洲和西方菜肴,以及血糖监测、运动和药物跟踪、症状筛查和体重记录。主要终点是HbA1c水平,次要终点包括空腹血糖(FPG)、低密度脂蛋白胆固醇、肾小球滤过率、BMI、自我保健行为和用户对该应用的满意度。该研究于2023年11月29日至2024年10月30日进行。结果:共纳入129名受试者(干预组:n=64, 49.6%;对照组:n=65, 50.4%)。干预组的参与者更年轻(平均年龄54.6岁,SD 14.3岁vs 61.9岁,SD 12.0岁;P= 0.002),而两组之间的基线HbA1c(平均9.3%,SD 1.96%)和FPG(平均179.5,SD 5.9 mg/dL)水平相似。6个月后,干预组HbA1c降低幅度明显高于对照组(平均差值-0.24%),但差异无统计学意义(P= 0.13)。结论:移动应用程序实现的血糖控制与通过标准护理实现的血糖控制相当,在65岁以下的参与者中FPG有显着改善。整合地区相关饮食内容的定制应用程序可能支持2型糖尿病患者有效的自我管理,并值得在更大规模的长期研究中进一步评估。
{"title":"A Tailor-Made Mobile App With a Local Cuisine Database for Self-Management of Type 2 Diabetes Mellitus: Randomized Controlled Trial.","authors":"Supasuta Wongdama, Wannaporn Paemueang, Chutintorn Sriphrapradang","doi":"10.2196/83685","DOIUrl":"10.2196/83685","url":null,"abstract":"<p><strong>Background: </strong>There are many mobile apps for diabetes self-management; however, most target Western populations and lack dietary content relevant to Asian contexts. Our mobile app addresses this gap by providing self-care tools and a database of regionally relevant foods.</p><p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of the app in improving glycemic control and self-care behaviors among outpatients with uncontrolled type 2 diabetes at our hospital.</p><p><strong>Methods: </strong>We conducted a randomized controlled trial with adults with type 2 diabetes, hemoglobin A1c (HbA1c) of >7%, and access to a smartphone. Participants were randomized to an intervention group (daily use of the Rama Diabetes Care app) or a control group (standard care), with all receiving diabetes self-management education and support. The app includes 6 features, notably a nutritional logging system with a verified database of Thai and commonly consumed foods, including Asian and Western dishes, as well as blood glucose monitoring, exercise and medication tracking, symptom screening, and weight logging. The primary outcome was HbA1c level, and secondary outcomes included fasting plasma glucose (FPG), low-density lipoprotein cholesterol, estimated glomerular filtration rate, BMI, self-care behaviors, and user satisfaction with the app. The study was conducted between November 29, 2023, and October 30, 2024.</p><p><strong>Results: </strong>A total of 129 participants were randomized (intervention: n=64, 49.6%; control: n=65, 50.4%). Participants in the intervention group were younger (mean age 54.6, SD 14.3 years vs 61.9, SD 12.0 years; P=.002), whereas baseline HbA1c (mean 9.3%, SD 1.96%) and FPG (mean 179.5, SD 5.9 mg/dL) levels were similar between the groups. Over 6 months, the intervention group showed a greater HbA1c reduction than the control group (mean difference -0.24%), but the difference was not statistically significant (P=.13). Among participants aged <65 years, FPG at 6 months was significantly lower in the intervention group (mean difference -29.3 mg/dL; P=.03). App satisfaction was rated as moderate.</p><p><strong>Conclusions: </strong>The mobile app achieved glycemic control comparable to that achieved through standard care, with significant improvement in FPG among participants younger than 65 years. Tailor-made apps integrating regionally relevant dietary content may support effective self-management in type 2 diabetes and warrant further evaluation in larger, long-term studies.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e83685"},"PeriodicalIF":2.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12747420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145858858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Bioimpedance for Physical Activity Detection in Type-2 Diabetes: Quasi-Experimental Validation Study. 数字生物阻抗用于2型糖尿病的身体活动检测:准实验验证研究。
IF 2.6 Q2 Medicine Pub Date : 2025-12-16 DOI: 10.2196/83768
Akira Kimura, Shinobu Onozawa, Takayuki Ogiwara, Marwan El Ghoch
<p><strong>Background: </strong>Primary care diabetes management lacks objective, scalable methods for continuous physical activity surveillance. Bioelectrical impedance analysis (BIA), routinely collected in diabetes care, offers untapped potential as an automated digital biomarker but requires validation for behavioral phenotyping.</p><p><strong>Objective: </strong>This study aims to evaluate the feasibility and predictive validity of multifrequency bioimpedance for physical activity detection and its association with glycemic control in type 2 diabetes.</p><p><strong>Methods: </strong>This was a pragmatic quasi-experimental study using temporal allocation across three 4-month periods (January 2021-July 2023) in a Japanese primary care clinic, including comprehensive tracking with BIA-guided counseling (n=65), partial tracking (n=31), and standard care (n=100). Adults with type 2 diabetes (hemoglobin A1c [HbA1c] 7.0%-10.0%) underwent monthly segmental multifrequency BIA. The primary outcome was HbA1c <7% at 4 months. Intervention-outcome associations were examined using chi-square trend tests and multivariable logistic regression adjusted for baseline HbA1c, the Walk Score (0-100), and medication indicators. To assess temporal confounding, we conducted ANCOVA on 4-month HbA1c with baseline adjustment (age and BMI added in sensitivity analyses). Effect modification by built environment was tested via Walk Score×Intervention interaction. Predictive validity of left-arm 50-kHz reactance was assessed using area under receiver operating characteristic curve with 95% CI via 10-fold cross-validation.</p><p><strong>Results: </strong>Among 196 participants, the baseline characteristics (age, BMI, HbA1c, diabetes duration, and medications) did not differ across periods (all P>.05). HbA1c <7% achievement showed a gradient: 80% (52/65) comprehensive, 58% (18/31) partial, and 56% (56/100) standard care (χ²4 for trend=14.23; P<.001). ANCOVA of 4-month HbA1c (baseline-adjusted) showed no linear period trend (P=.25). A significant Walk Score×Intervention interaction was observed (β per 10-point Walk Score=-.55; 95% CI -1.03 to -0.06; P=.028), indicating differential effectiveness by neighborhood walkability. Left-arm 50-kHz reactance predicted target achievement (adjusted odds ratio per 1-SD increase =3.04; 95% CI 1.86-4.97; P<.001; area under receiver operating characteristic curve=0.847, 95% CI 0.784-0.910). Among achievers, reactance change correlated with HbA1c change (r=-0.392; P=.032) but not among nonachievers (r=-0.089; P=.54). After the inverse probability weighting was stabilized, each 1-SD increase in left-arm reactance was associated with a 12.1 percentage-point higher probability of target achievement (95% CI 5.2%-19.0%).</p><p><strong>Conclusions: </strong>This pragmatic implementation study demonstrates that automated BIA is feasible for routine diabetes care and suggests potential as a digital biomarker of activity-related glycemic control. Whi
背景:初级保健糖尿病管理缺乏持续监测身体活动的客观、可扩展的方法。生物电阻抗分析(BIA)是糖尿病护理中常规收集的数据,作为一种自动化数字生物标志物具有未开发的潜力,但需要对行为表型进行验证。目的:本研究旨在评价多频生物阻抗检测2型糖尿病患者体力活动的可行性、预测有效性及其与血糖控制的关系。方法:这是一项实用的准实验研究,在日本一家初级保健诊所使用三个4个月的时间分配(2021年1月至2023年7月),包括采用bia指导咨询的全面跟踪(n=65),部分跟踪(n=31)和标准治疗(n=100)。成人2型糖尿病患者(血红蛋白A1c [HbA1c] 7.0%-10.0%)每月接受分段多频BIA。主要结局是HbA1c结果:在196名参与者中,基线特征(年龄、BMI、HbA1c、糖尿病病程和药物)在不同时期没有差异(P < 0.05)。结论:这项实用的实施研究表明,自动化BIA在常规糖尿病护理中是可行的,并具有作为活动相关血糖控制的数字生物标志物的潜力。虽然时间分配排除了明确的因果推断,研究结果应被解释为相关性,但观察到的步行评分调节和生物阻抗- hba1c剂量反应模式与行为机制一致,而不是纯粹的混淆。左臂电抗作为一种可扩展的、被动的糖尿病精确管理监测工具,需要随机验证。
{"title":"Digital Bioimpedance for Physical Activity Detection in Type-2 Diabetes: Quasi-Experimental Validation Study.","authors":"Akira Kimura, Shinobu Onozawa, Takayuki Ogiwara, Marwan El Ghoch","doi":"10.2196/83768","DOIUrl":"10.2196/83768","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Primary care diabetes management lacks objective, scalable methods for continuous physical activity surveillance. Bioelectrical impedance analysis (BIA), routinely collected in diabetes care, offers untapped potential as an automated digital biomarker but requires validation for behavioral phenotyping.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to evaluate the feasibility and predictive validity of multifrequency bioimpedance for physical activity detection and its association with glycemic control in type 2 diabetes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a pragmatic quasi-experimental study using temporal allocation across three 4-month periods (January 2021-July 2023) in a Japanese primary care clinic, including comprehensive tracking with BIA-guided counseling (n=65), partial tracking (n=31), and standard care (n=100). Adults with type 2 diabetes (hemoglobin A1c [HbA1c] 7.0%-10.0%) underwent monthly segmental multifrequency BIA. The primary outcome was HbA1c &lt;7% at 4 months. Intervention-outcome associations were examined using chi-square trend tests and multivariable logistic regression adjusted for baseline HbA1c, the Walk Score (0-100), and medication indicators. To assess temporal confounding, we conducted ANCOVA on 4-month HbA1c with baseline adjustment (age and BMI added in sensitivity analyses). Effect modification by built environment was tested via Walk Score×Intervention interaction. Predictive validity of left-arm 50-kHz reactance was assessed using area under receiver operating characteristic curve with 95% CI via 10-fold cross-validation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 196 participants, the baseline characteristics (age, BMI, HbA1c, diabetes duration, and medications) did not differ across periods (all P&gt;.05). HbA1c &lt;7% achievement showed a gradient: 80% (52/65) comprehensive, 58% (18/31) partial, and 56% (56/100) standard care (χ²4 for trend=14.23; P&lt;.001). ANCOVA of 4-month HbA1c (baseline-adjusted) showed no linear period trend (P=.25). A significant Walk Score×Intervention interaction was observed (β per 10-point Walk Score=-.55; 95% CI -1.03 to -0.06; P=.028), indicating differential effectiveness by neighborhood walkability. Left-arm 50-kHz reactance predicted target achievement (adjusted odds ratio per 1-SD increase =3.04; 95% CI 1.86-4.97; P&lt;.001; area under receiver operating characteristic curve=0.847, 95% CI 0.784-0.910). Among achievers, reactance change correlated with HbA1c change (r=-0.392; P=.032) but not among nonachievers (r=-0.089; P=.54). After the inverse probability weighting was stabilized, each 1-SD increase in left-arm reactance was associated with a 12.1 percentage-point higher probability of target achievement (95% CI 5.2%-19.0%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This pragmatic implementation study demonstrates that automated BIA is feasible for routine diabetes care and suggests potential as a digital biomarker of activity-related glycemic control. Whi","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e83768"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Carbohydrate Nutrition Counseling With Continuous Glucose Monitoring to Improve Metabolic Health Among Veterans With Type 2 Diabetes: Pilot Quality Improvement Initiative Study. 低碳水化合物营养咨询与持续血糖监测改善2型糖尿病退伍军人的代谢健康:试点质量改善倡议研究
IF 2.6 Q2 Medicine Pub Date : 2025-12-15 DOI: 10.2196/75672
Cassie D Turner, Kishor Patel, Katherine Freeman, Lyndsay Ruff, Jamie Michaels, Timothy Bodnar, Laura R Saslow, James Henderson, Lauren Oshman, Caroline R Richardson, Devvrat Malhotra, A Mark Fendrick, Garth Strohbehn, Dina H Griauzde
<p><strong>Background: </strong>One in 4 Veterans who receive care through the Veterans Health Administration has type 2 diabetes (T2D). Dietary carbohydrate restriction can promote weight loss and improve blood glucose control, but Veterans taking certain medications (eg, insulin) may experience serious complications (eg, hypoglycemia) without adequate support and monitoring.</p><p><strong>Objective: </strong>This study aims to develop and evaluate the feasibility, acceptability, and clinical effectiveness of a pilot low-carbohydrate (LC) nutrition counseling program guided by continuous glucose monitoring (CGM) for Veterans with T2D receiving insulin (ie, LC-CGM).</p><p><strong>Methods: </strong>This is a pragmatic, nonrandomized, pre-post quality improvement pilot program. Eligible patients were Veterans with T2D who were prescribed ≥3 daily injections of insulin. The 24-week LC-CGM program consisted of virtual visits with a registered dietitian (RD) and clinical pharmacy practitioner (CPP); CGM data were used to guide tailored nutrition counseling and de-escalation or cessation of glucose-lowering medications. To evaluate changes from baseline, intention-to-treat analyses were conducted for all enrollees, with separate analyses for program completers. Primary outcomes were program feasibility and acceptability (ie, program enrollment and completion rates and mean number of RD and CPP visits). Secondary outcomes included mean weight change, percent weight loss, achievement of ≥5% and ≥10% weight loss, change in glucose-lowering medication use, and change in laboratory measures (eg, hemoglobin A1c [HbA1c]).</p><p><strong>Results: </strong>Program evaluation occurred from March 19, 2021, to May 3, 2024. Among 43 Veterans referred to the LC-CGM program, 38 (88%) enrolled. Most were men (37/38, 97%), white (29/38, 76%), with an average age of 63.7 (SD 9.6) years. Mean BMI and HbA1c were 38.1 (SD 5.8) kg/m2 and 7.8% (SD 1.3). Of 38 enrollees, 27 (71%) completed the program. Enrollees averaged 9.5 (SD 3.3) RD visits and 12.8 (SD 4.7) CPP visits. In intention-to-treat analyses, mean weight change was -11.5 kilograms (SD 8.7; 95% CI -14.4 to -8.6), corresponding to 9.5% weight loss (SD 7.2; 95% CI -14.9 to -4.2), with 58% (22/38) achieving ≥5% weight loss and 32% (12/38) achieving ≥10% weight loss. Overall, use of glucose-lowering medications decreased from 3.5 (SD 0.8) per patient at baseline to 2.4 (SD 0.9) per patient at 24 weeks (P<.001), with 72% (26/36) of Veterans discontinuing short-acting insulin and 50% (18/36; P<.001) discontinuing long-acting insulin. Use of glucagon-like peptide-1 receptor agonists increased from 39% (15/38) at baseline to 61% (23/38) at 24 weeks (P=.02). Among program completers (n=27), mean percent weight loss was -11.8% (SD 6.5) and median HbA1c decreased by 0.7% (95% CI -0.9 to -0.3; P=.001).</p><p><strong>Conclusions: </strong>This pilot program provides preliminary evidence that supports feasibility, acceptability,
背景:四分之一接受退伍军人健康管理局护理的退伍军人患有2型糖尿病(T2D)。饮食碳水化合物限制可以促进减肥和改善血糖控制,但退伍军人服用某些药物(如胰岛素)可能会遇到严重的并发症(如低血糖),没有足够的支持和监测。目的:本研究旨在为接受胰岛素治疗的t2dm退伍军人(即LC-CGM)制定并评估以连续血糖监测(CGM)为指导的低碳水化合物(LC)营养咨询试点方案的可行性、可接受性和临床效果。方法:这是一个务实的、非随机的、岗前质量改进试点项目。符合条件的患者是患有T2D的退伍军人,每天注射胰岛素≥3次。为期24周的LC-CGM计划包括与注册营养师(RD)和临床药学从业者(CPP)进行虚拟访问;CGM数据用于指导量身定制的营养咨询和降糖药物的降级或停止。为了评估从基线开始的变化,对所有入组者进行意向治疗分析,并对项目完成者进行单独分析。主要结果是项目的可行性和可接受性(即项目的入组率和完成率以及RD和CPP就诊的平均次数)。次要结局包括平均体重变化、体重减轻百分比、体重减轻≥5%和≥10%、降糖药物使用的变化和实验室测量的变化(如血红蛋白A1c [HbA1c])。结果:项目评估时间为2021年3月19日至2024年5月3日。在参与LC-CGM项目的43名退伍军人中,38人(88%)注册。多数为男性(37/ 38,97%),白人(29/ 38,76%),平均年龄63.7岁(SD 9.6)。平均BMI和HbA1c分别为38.1 (SD 5.8) kg/m2和7.8% (SD 1.3)。在38名参与者中,27人(71%)完成了该项目。受试者平均RD访问9.5次(SD 3.3), CPP访问12.8次(SD 4.7)。在意向治疗分析中,平均体重变化为-11.5 kg (SD 8.7; 95% CI -14.4至-8.6),相当于体重减轻9.5% (SD 7.2; 95% CI -14.9至-4.2),其中58%(22/38)达到体重减轻≥5%,32%(12/38)达到体重减轻≥10%。总体而言,降糖药物的使用从基线时的每名患者3.5 (SD 0.8)下降到24周时的每名患者2.4 (SD 0.9)。结论:该试点项目为t2dm退伍军人的可行性、可接受性和临床有效性提供了初步证据。需要进一步的研究来严格测试更大的符合条件的退伍军人群体的长期临床和成本效益。
{"title":"Low-Carbohydrate Nutrition Counseling With Continuous Glucose Monitoring to Improve Metabolic Health Among Veterans With Type 2 Diabetes: Pilot Quality Improvement Initiative Study.","authors":"Cassie D Turner, Kishor Patel, Katherine Freeman, Lyndsay Ruff, Jamie Michaels, Timothy Bodnar, Laura R Saslow, James Henderson, Lauren Oshman, Caroline R Richardson, Devvrat Malhotra, A Mark Fendrick, Garth Strohbehn, Dina H Griauzde","doi":"10.2196/75672","DOIUrl":"10.2196/75672","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;One in 4 Veterans who receive care through the Veterans Health Administration has type 2 diabetes (T2D). Dietary carbohydrate restriction can promote weight loss and improve blood glucose control, but Veterans taking certain medications (eg, insulin) may experience serious complications (eg, hypoglycemia) without adequate support and monitoring.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to develop and evaluate the feasibility, acceptability, and clinical effectiveness of a pilot low-carbohydrate (LC) nutrition counseling program guided by continuous glucose monitoring (CGM) for Veterans with T2D receiving insulin (ie, LC-CGM).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This is a pragmatic, nonrandomized, pre-post quality improvement pilot program. Eligible patients were Veterans with T2D who were prescribed ≥3 daily injections of insulin. The 24-week LC-CGM program consisted of virtual visits with a registered dietitian (RD) and clinical pharmacy practitioner (CPP); CGM data were used to guide tailored nutrition counseling and de-escalation or cessation of glucose-lowering medications. To evaluate changes from baseline, intention-to-treat analyses were conducted for all enrollees, with separate analyses for program completers. Primary outcomes were program feasibility and acceptability (ie, program enrollment and completion rates and mean number of RD and CPP visits). Secondary outcomes included mean weight change, percent weight loss, achievement of ≥5% and ≥10% weight loss, change in glucose-lowering medication use, and change in laboratory measures (eg, hemoglobin A1c [HbA1c]).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Program evaluation occurred from March 19, 2021, to May 3, 2024. Among 43 Veterans referred to the LC-CGM program, 38 (88%) enrolled. Most were men (37/38, 97%), white (29/38, 76%), with an average age of 63.7 (SD 9.6) years. Mean BMI and HbA1c were 38.1 (SD 5.8) kg/m2 and 7.8% (SD 1.3). Of 38 enrollees, 27 (71%) completed the program. Enrollees averaged 9.5 (SD 3.3) RD visits and 12.8 (SD 4.7) CPP visits. In intention-to-treat analyses, mean weight change was -11.5 kilograms (SD 8.7; 95% CI -14.4 to -8.6), corresponding to 9.5% weight loss (SD 7.2; 95% CI -14.9 to -4.2), with 58% (22/38) achieving ≥5% weight loss and 32% (12/38) achieving ≥10% weight loss. Overall, use of glucose-lowering medications decreased from 3.5 (SD 0.8) per patient at baseline to 2.4 (SD 0.9) per patient at 24 weeks (P&lt;.001), with 72% (26/36) of Veterans discontinuing short-acting insulin and 50% (18/36; P&lt;.001) discontinuing long-acting insulin. Use of glucagon-like peptide-1 receptor agonists increased from 39% (15/38) at baseline to 61% (23/38) at 24 weeks (P=.02). Among program completers (n=27), mean percent weight loss was -11.8% (SD 6.5) and median HbA1c decreased by 0.7% (95% CI -0.9 to -0.3; P=.001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This pilot program provides preliminary evidence that supports feasibility, acceptability, ","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e75672"},"PeriodicalIF":2.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12705128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin Injection Technique Education and Associated Knowledge Factors Among Physicians: Cross-Sectional Survey Study. 医师胰岛素注射技术教育及相关知识因素:横断面调查研究。
IF 2.6 Q2 Medicine Pub Date : 2025-12-08 DOI: 10.2196/65359
Ida Ayu Made Kshanti, Nadya Magfira, Anak Agung Arie Widyastuti, Jerry Nasarudin, Marina Epriliawati, Md Ikhsan Mokoagow

Background: Insulin therapy is crucial for managing type 2 diabetes mellitus, with its use steadily increasing in Indonesia and its effectiveness well established. However, prescribing insulin poses various challenges that can impact the effectiveness of insulin. Patient education is crucial for the successful implementation of insulin therapy. Proper insulin use remains insufficient in Indonesia.

Objective: This study aims to investigate physicians' knowledge and practice in providing education on insulin use to patients with type 2 diabetes mellitus in Indonesia.

Methods: This study recruited potential participants (all physicians in Indonesia) through the internet using a convenience sampling method. The participants were asked to fill out a questionnaire. The questionnaire had 32 questions divided into 4 sections: demographics and clinical practice, practice of insulin education, the Indonesian insulin injection technique guideline, and knowledge of insulin injection techniques. The instrument used in this study was developed based on the Pedoman Teknik Menyuntik Insulin Indonesia, which was adapted from the international consensus by the Forum for Injection Technique and Therapy Expert Recommendations. The survey lasted from February 2021 to March 2021. Data were analyzed using the Kruskal-Wallis tests.

Results: A total of 823 participants were included in the analysis. Out of 823 participants, 680 (82.6%) had given insulin education to patients at least once during the last 30 days. However, out of 823 participants, only 479 (58.2%) used specific guidelines in their practice, with only 280 (34.0%) aware of the Indonesian guidelines. Out of 823 participants, 815 (99.1%) agreed that insulin injection techniques would affect clinical results. The median score of knowledge about insulin injection techniques was 7 (IQR 2) among the study participants, indicating good knowledge. Profession was the only variable significantly associated with knowledge scores, with consultants in endocrinology, metabolism, and diabetes achieving the highest median scores, and other physicians the lowest (P<.001).

Conclusions: Most physicians in this study reported providing education to their patients. However, there was still a gap between the guidelines and the practice of insulin education, as indicated by the lack of awareness and a fair level of knowledge about the Indonesian guidelines.

背景:胰岛素治疗对2型糖尿病的治疗至关重要,在印度尼西亚胰岛素的使用稳步增加,其有效性也得到了很好的证实。然而,处方胰岛素带来了各种各样的挑战,可能会影响胰岛素的有效性。患者教育对于胰岛素治疗的成功实施至关重要。在印度尼西亚,适当的胰岛素使用仍然不足。目的:了解印尼医生对2型糖尿病患者进行胰岛素使用教育的知识和实践情况。方法:本研究采用方便的抽样方法,通过互联网招募潜在的参与者(印度尼西亚的所有医生)。参与者被要求填写一份问卷。问卷共32题,分为人口统计学与临床实践、胰岛素教育实践、印尼胰岛素注射技术指南、胰岛素注射技术知识4个部分。本研究中使用的仪器是根据印度尼西亚的Pedoman Teknik Menyuntik胰岛素开发的,该胰岛素是根据注射技术和治疗专家建议论坛的国际共识改编的。该调查从2021年2月持续到2021年3月。使用Kruskal-Wallis检验分析数据。结果:共纳入823名参与者。在823名参与者中,680名(82.6%)在过去30天内至少对患者进行过一次胰岛素教育。然而,在823名参与者中,只有479人(58.2%)在实践中使用了具体的指导方针,只有280人(34.0%)知道印度尼西亚的指导方针。在823名参与者中,815人(99.1%)同意胰岛素注射技术会影响临床结果。研究对象对胰岛素注射技术知识的中位数得分为7分(IQR 2),表明知识较好。职业是唯一与知识得分显著相关的变量,内分泌科、代谢科和糖尿病科的咨询师的中位数得分最高,而其他医生的中位数得分最低(结论:本研究中大多数医生报告向患者提供教育。但是,指南与胰岛素教育的实践之间仍然存在差距,这表明缺乏对印度尼西亚指南的认识和相当程度的知识。
{"title":"Insulin Injection Technique Education and Associated Knowledge Factors Among Physicians: Cross-Sectional Survey Study.","authors":"Ida Ayu Made Kshanti, Nadya Magfira, Anak Agung Arie Widyastuti, Jerry Nasarudin, Marina Epriliawati, Md Ikhsan Mokoagow","doi":"10.2196/65359","DOIUrl":"10.2196/65359","url":null,"abstract":"<p><strong>Background: </strong>Insulin therapy is crucial for managing type 2 diabetes mellitus, with its use steadily increasing in Indonesia and its effectiveness well established. However, prescribing insulin poses various challenges that can impact the effectiveness of insulin. Patient education is crucial for the successful implementation of insulin therapy. Proper insulin use remains insufficient in Indonesia.</p><p><strong>Objective: </strong>This study aims to investigate physicians' knowledge and practice in providing education on insulin use to patients with type 2 diabetes mellitus in Indonesia.</p><p><strong>Methods: </strong>This study recruited potential participants (all physicians in Indonesia) through the internet using a convenience sampling method. The participants were asked to fill out a questionnaire. The questionnaire had 32 questions divided into 4 sections: demographics and clinical practice, practice of insulin education, the Indonesian insulin injection technique guideline, and knowledge of insulin injection techniques. The instrument used in this study was developed based on the Pedoman Teknik Menyuntik Insulin Indonesia, which was adapted from the international consensus by the Forum for Injection Technique and Therapy Expert Recommendations. The survey lasted from February 2021 to March 2021. Data were analyzed using the Kruskal-Wallis tests.</p><p><strong>Results: </strong>A total of 823 participants were included in the analysis. Out of 823 participants, 680 (82.6%) had given insulin education to patients at least once during the last 30 days. However, out of 823 participants, only 479 (58.2%) used specific guidelines in their practice, with only 280 (34.0%) aware of the Indonesian guidelines. Out of 823 participants, 815 (99.1%) agreed that insulin injection techniques would affect clinical results. The median score of knowledge about insulin injection techniques was 7 (IQR 2) among the study participants, indicating good knowledge. Profession was the only variable significantly associated with knowledge scores, with consultants in endocrinology, metabolism, and diabetes achieving the highest median scores, and other physicians the lowest (P<.001).</p><p><strong>Conclusions: </strong>Most physicians in this study reported providing education to their patients. However, there was still a gap between the guidelines and the practice of insulin education, as indicated by the lack of awareness and a fair level of knowledge about the Indonesian guidelines.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e65359"},"PeriodicalIF":2.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Innovative Insulin Dose Self-Titration Toolkit for Adults Living With Type 2 Diabetes Mellitus. 一种用于2型糖尿病患者的创新型胰岛素剂量自我滴定工具。
IF 2.6 Q2 Medicine Pub Date : 2025-11-26 DOI: 10.2196/75903
Nadin Abbas, Heather Lochnan, Sandhya Goge, Annie Garon-Mailer, Cathy J Sun

Unlabelled: We developed an innovative bilingual toolkit comprising a personalized action plan and educational videos to encourage insulin dose self-titration by adults living with type 2 diabetes.

无标签:我们开发了一个创新的双语工具包,包括个性化的行动计划和教育视频,以鼓励成人2型糖尿病患者自我计量胰岛素剂量。
{"title":"An Innovative Insulin Dose Self-Titration Toolkit for Adults Living With Type 2 Diabetes Mellitus.","authors":"Nadin Abbas, Heather Lochnan, Sandhya Goge, Annie Garon-Mailer, Cathy J Sun","doi":"10.2196/75903","DOIUrl":"10.2196/75903","url":null,"abstract":"<p><strong>Unlabelled: </strong>We developed an innovative bilingual toolkit comprising a personalized action plan and educational videos to encourage insulin dose self-titration by adults living with type 2 diabetes.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e75903"},"PeriodicalIF":2.6,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12661589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a Personalized Basal Tuner for Detecting Basal Rate Inaccuracies in Type 1 Diabetes Mellitus Without Meal Data: Algorithm Development and Retrospective Validation Study. 用于检测1型糖尿病无膳食数据基础率不准确性的个性化基础调谐器:算法开发和回顾性验证研究。
IF 2.6 Q2 Medicine Pub Date : 2025-11-26 DOI: 10.2196/72769
Daniel Gasca Garcia, Hood Thabit, Paul W Nutter, Simon Harper

Background: Basal rate (BR) adjustment is crucial for managing type 1 diabetes mellitus, accounting for 30% to 50% of total daily insulin needs. All current closed-loop systems revert to the user's usual pump BR (known as manual mode) in the event of closed loop failure. Furthermore, access to closed-loop systems remains relatively low in low- and middle-income countries and among those without suitable health insurance. Accurately adjusting the BR remains challenging, leading to hypo- or hyperglycemia, and research on optimizing the BR is limited.

Objective: This study proposed an adaptive algorithm that uses continuous glucose monitoring data to identify BR inaccuracies without requiring meal intake information.

Methods: The OhioT1DM dataset formed the basis for implementing this methodology. Each composite day was generated by excluding bolus insulin profiles lacking meal intake information and by calculating hourly blood glucose (BG) relative levels along with their corresponding reliability measures, enabling assessment of deviations from the recommended BR (ie, a BG relative change of 0 mg/dL). Both a noninferiority analysis and a classification precision metric were used to assess the practicality of this approach compared to using meal data.

Results: Data from 12 participants showed noninferiority of the no-meal method: using a 20% noninferiority margin on absolute BG relative change, 9 of 12 participants met the criterion (1-sided P<.05). Classification precision was 73.9% (139/188) of meals correctly classified on average per participant (SD 11.8%; 95% CI 67.2%-79.7%). The daily cumulative BG average was 200.6 mg/dL (SD 61.7 mg/dL; 11.1 mmol/L, SD 3.4 mmol/L; 95% CI 161.4-239.8 mg/dL), with peak values reaching 270.15 mg/dL (14.99 mmol/L). Furthermore, 99.3% (286/288) of the BG relative values (SD 0.5%; 95% CI 97.5%-99.8%) that were unaffected by external factors were associated with incorrect BR settings, with deviations ranging from -25.5 to 46 mg/dL (-1.58 to 2.59 mmol/L).

Conclusions: Current strategies to optimize BR settings are inadequate, and our approach of a personalized basal tuner (PBT) helps better analyze BR without relying on meal intake information. Indeed, without an optimally set BR, in the event of the closed loop reverting to manual mode, patients may be exposed to persistent hypo- or hyperglycemia, leading to safety and efficacy issues. Future work will focus on generating BR recommendations through the application of this algorithm in clinical practice to assist clinicians in setting BR in low- and middle-income countries, where closed-loop systems are not prevalent, to help increase time in range.

背景:基础率(BR)的调整对1型糖尿病的治疗至关重要,占每日总胰岛素需要量的30%至50%。在闭环故障的情况下,所有当前的闭环系统都恢复到用户通常的泵BR(称为手动模式)。此外,在低收入和中等收入国家以及在没有适当医疗保险的人群中,获得闭环系统的机会仍然相对较低。准确调整BR仍然是一个挑战,导致低血糖或高血糖,优化BR的研究是有限的。目的:本研究提出了一种自适应算法,该算法在不需要膳食摄入信息的情况下,使用连续血糖监测数据识别BR不准确。方法:OhioT1DM数据集构成了实施该方法的基础。每个复合日的生成是通过排除缺乏膳食摄入信息的大剂量胰岛素谱,并通过计算每小时血糖(BG)相对水平及其相应的可靠性措施,从而评估与推荐BR的偏差(即BG相对变化为0 mg/dL)。采用非劣效性分析和分类精度度量来评估该方法与使用膳食数据相比的实用性。结果:来自12名参与者的数据显示无餐法的非劣效性:使用绝对BG相对变化的20%非劣效性裕度,12名参与者中有9人符合标准(单侧p)。结论:目前优化BR设置的策略是不足的,我们的个性化基础调谐器(PBT)方法有助于更好地分析BR,而不依赖于膳食摄入信息。事实上,如果没有最佳设定的BR,在闭环恢复到手动模式的情况下,患者可能会暴露于持续的低血糖或高血糖,从而导致安全性和有效性问题。未来的工作将侧重于通过在临床实践中应用该算法产生BR建议,以帮助临床医生在闭环系统不普遍的低收入和中等收入国家设置BR,以帮助增加范围时间。
{"title":"Toward a Personalized Basal Tuner for Detecting Basal Rate Inaccuracies in Type 1 Diabetes Mellitus Without Meal Data: Algorithm Development and Retrospective Validation Study.","authors":"Daniel Gasca Garcia, Hood Thabit, Paul W Nutter, Simon Harper","doi":"10.2196/72769","DOIUrl":"10.2196/72769","url":null,"abstract":"<p><strong>Background: </strong>Basal rate (BR) adjustment is crucial for managing type 1 diabetes mellitus, accounting for 30% to 50% of total daily insulin needs. All current closed-loop systems revert to the user's usual pump BR (known as manual mode) in the event of closed loop failure. Furthermore, access to closed-loop systems remains relatively low in low- and middle-income countries and among those without suitable health insurance. Accurately adjusting the BR remains challenging, leading to hypo- or hyperglycemia, and research on optimizing the BR is limited.</p><p><strong>Objective: </strong>This study proposed an adaptive algorithm that uses continuous glucose monitoring data to identify BR inaccuracies without requiring meal intake information.</p><p><strong>Methods: </strong>The OhioT1DM dataset formed the basis for implementing this methodology. Each composite day was generated by excluding bolus insulin profiles lacking meal intake information and by calculating hourly blood glucose (BG) relative levels along with their corresponding reliability measures, enabling assessment of deviations from the recommended BR (ie, a BG relative change of 0 mg/dL). Both a noninferiority analysis and a classification precision metric were used to assess the practicality of this approach compared to using meal data.</p><p><strong>Results: </strong>Data from 12 participants showed noninferiority of the no-meal method: using a 20% noninferiority margin on absolute BG relative change, 9 of 12 participants met the criterion (1-sided P<.05). Classification precision was 73.9% (139/188) of meals correctly classified on average per participant (SD 11.8%; 95% CI 67.2%-79.7%). The daily cumulative BG average was 200.6 mg/dL (SD 61.7 mg/dL; 11.1 mmol/L, SD 3.4 mmol/L; 95% CI 161.4-239.8 mg/dL), with peak values reaching 270.15 mg/dL (14.99 mmol/L). Furthermore, 99.3% (286/288) of the BG relative values (SD 0.5%; 95% CI 97.5%-99.8%) that were unaffected by external factors were associated with incorrect BR settings, with deviations ranging from -25.5 to 46 mg/dL (-1.58 to 2.59 mmol/L).</p><p><strong>Conclusions: </strong>Current strategies to optimize BR settings are inadequate, and our approach of a personalized basal tuner (PBT) helps better analyze BR without relying on meal intake information. Indeed, without an optimally set BR, in the event of the closed loop reverting to manual mode, patients may be exposed to persistent hypo- or hyperglycemia, leading to safety and efficacy issues. Future work will focus on generating BR recommendations through the application of this algorithm in clinical practice to assist clinicians in setting BR in low- and middle-income countries, where closed-loop systems are not prevalent, to help increase time in range.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e72769"},"PeriodicalIF":2.6,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12661609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coefficient of Variation to Assess the Reproducibility of Meal-Induced Glycemic Responses: Development of a Clustering Algorithm. 评估膳食诱导血糖反应可重复性的变异系数:聚类算法的发展。
IF 2.6 Q2 Medicine Pub Date : 2025-11-20 DOI: 10.2196/68821
Nicole Lubasinski, Hood Thabit, Paul W Nutter, David Petrescu, Simon Harper

Background: Managing type 1 diabetes (T1D) requires maintaining target blood glucose levels through precise diet and insulin dosing. Predicting postprandial glycemic responses (PPGRs) based solely on carbohydrate content is limited by factors such as meal composition, individual physiology, and lifestyle. Continuous glucose monitors provide insights into these responses, revealing significant individual variability. The statistical clustering method proposed here balances the number of clusters formed and the glycemic variability of the PPGRs within each cluster to offer a clustering technique on which treatment decisions could be based.

Objective: This study aims to develop and evaluate a PPGR clustering method that identifies reproducible meal-specific glucose patterns in people with type 1 diabetes.

Methods: Blood glucose data from the OhioT1DM dataset were used to assess clustering of PPGR based on the coefficient of variability (CV) of glucose. Clustering was performed using statistical clustering, with each PPGR isolated into 48 data points per event. A CV threshold of <36% was used to define clinically similar clusters. This aimed to cluster PPGRs with minimal glycemic variability. The approach aims to enhance precision in analyzing postprandial glycemic dynamics, assessing cluster cohesion via standard deviation and CV within meal categories.

Results: The analysis revealed a reproducible set of PPGR clusters specific to meal types and individuals (mean [SD], 2.4 [1.8] for breakfast, 2.7 [0.9] for lunch, and 3.1 [1.0] for dinner), with the number of clusters varying across participants and meals in the dataset. Carbohydrate intake alone did not affect cluster formation, suggesting a complex relationship between meal composition and PPGR variability. However, certain individuals showed significant associations between carbohydrate intake and cluster formation for specific meals.

Conclusions: The meal-based glycemic clustering algorithm provides a promising framework for predicting PPGRs in people with type 1 diabetes, independent of carbohydrate intake. It emphasizes the need for personalized prediction models to optimize time in range and enhance diabetes management. Efforts to refine treatment strategies are crucial in reducing T1D-related complications.

背景:管理1型糖尿病(T1D)需要通过精确的饮食和胰岛素剂量来维持目标血糖水平。仅根据碳水化合物含量预测餐后血糖反应(ppgr)受到膳食成分、个体生理和生活方式等因素的限制。连续血糖监测提供了对这些反应的洞察,揭示了显著的个体差异。本文提出的统计聚类方法平衡了形成的聚类数量和每个聚类中ppgr的血糖变异性,从而提供了一种聚类技术,可以根据这种聚类技术做出治疗决策。目的:本研究旨在开发和评估一种PPGR聚类方法,用于识别1型糖尿病患者可重复的膳食特异性葡萄糖模式。方法:使用来自OhioT1DM数据集的血糖数据,基于葡萄糖的变异性系数(CV)评估PPGR的聚类。使用统计聚类执行聚类,每个PPGR每个事件被隔离为48个数据点。结果的CV阈值:分析显示了一组特定于膳食类型和个体的可重复的PPGR聚类(平均[SD],早餐为2.4[1.8],午餐为2.7[0.9],晚餐为3.1[1.0]),聚类的数量在数据集中因参与者和膳食而异。单独的碳水化合物摄入不会影响团簇的形成,这表明膳食成分和PPGR变异性之间存在复杂的关系。然而,某些个体表现出碳水化合物摄入量与特定膳食的簇形成之间的显著关联。结论:基于膳食的血糖聚类算法为预测1型糖尿病患者的ppgr提供了一个有希望的框架,与碳水化合物摄入量无关。它强调需要个性化的预测模型来优化时间范围和加强糖尿病管理。努力改进治疗策略对于减少t1d相关并发症至关重要。
{"title":"Coefficient of Variation to Assess the Reproducibility of Meal-Induced Glycemic Responses: Development of a Clustering Algorithm.","authors":"Nicole Lubasinski, Hood Thabit, Paul W Nutter, David Petrescu, Simon Harper","doi":"10.2196/68821","DOIUrl":"10.2196/68821","url":null,"abstract":"<p><strong>Background: </strong>Managing type 1 diabetes (T1D) requires maintaining target blood glucose levels through precise diet and insulin dosing. Predicting postprandial glycemic responses (PPGRs) based solely on carbohydrate content is limited by factors such as meal composition, individual physiology, and lifestyle. Continuous glucose monitors provide insights into these responses, revealing significant individual variability. The statistical clustering method proposed here balances the number of clusters formed and the glycemic variability of the PPGRs within each cluster to offer a clustering technique on which treatment decisions could be based.</p><p><strong>Objective: </strong>This study aims to develop and evaluate a PPGR clustering method that identifies reproducible meal-specific glucose patterns in people with type 1 diabetes.</p><p><strong>Methods: </strong>Blood glucose data from the OhioT1DM dataset were used to assess clustering of PPGR based on the coefficient of variability (CV) of glucose. Clustering was performed using statistical clustering, with each PPGR isolated into 48 data points per event. A CV threshold of <36% was used to define clinically similar clusters. This aimed to cluster PPGRs with minimal glycemic variability. The approach aims to enhance precision in analyzing postprandial glycemic dynamics, assessing cluster cohesion via standard deviation and CV within meal categories.</p><p><strong>Results: </strong>The analysis revealed a reproducible set of PPGR clusters specific to meal types and individuals (mean [SD], 2.4 [1.8] for breakfast, 2.7 [0.9] for lunch, and 3.1 [1.0] for dinner), with the number of clusters varying across participants and meals in the dataset. Carbohydrate intake alone did not affect cluster formation, suggesting a complex relationship between meal composition and PPGR variability. However, certain individuals showed significant associations between carbohydrate intake and cluster formation for specific meals.</p><p><strong>Conclusions: </strong>The meal-based glycemic clustering algorithm provides a promising framework for predicting PPGRs in people with type 1 diabetes, independent of carbohydrate intake. It emphasizes the need for personalized prediction models to optimize time in range and enhance diabetes management. Efforts to refine treatment strategies are crucial in reducing T1D-related complications.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e68821"},"PeriodicalIF":2.6,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12633838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Language AI Models and Pediatric Type 1 Diabetes: Can Chatbots Help With Diabetes Self-Management and Patient Education? 自然语言人工智能模型和儿童1型糖尿病:聊天机器人能帮助糖尿病自我管理和患者教育吗?
IF 2.6 Q2 Medicine Pub Date : 2025-11-07 DOI: 10.2196/76986
Flavia Voiculescu, Paul Darvasi, Esli Osmanlliu, Preetha Krishnamoorthy, Angeliki Makri

Unlabelled: Diabetes self-management plays a major role in controlling blood sugar levels and avoiding chronic complications. In this report, we investigate the strengths and limitations of artificial intelligence chatbots in supporting patients with type 1 diabetes and their families. With the growing accessibility of these constantly evolving tools, front-line providers must advocate for their responsible use.

未标示:糖尿病自我管理在控制血糖水平和避免慢性并发症方面起着重要作用。在本报告中,我们研究了人工智能聊天机器人在支持1型糖尿病患者及其家人方面的优势和局限性。随着这些不断发展的工具越来越容易获得,一线提供者必须提倡负责任地使用它们。
{"title":"Natural Language AI Models and Pediatric Type 1 Diabetes: Can Chatbots Help With Diabetes Self-Management and Patient Education?","authors":"Flavia Voiculescu, Paul Darvasi, Esli Osmanlliu, Preetha Krishnamoorthy, Angeliki Makri","doi":"10.2196/76986","DOIUrl":"10.2196/76986","url":null,"abstract":"<p><strong>Unlabelled: </strong>Diabetes self-management plays a major role in controlling blood sugar levels and avoiding chronic complications. In this report, we investigate the strengths and limitations of artificial intelligence chatbots in supporting patients with type 1 diabetes and their families. With the growing accessibility of these constantly evolving tools, front-line providers must advocate for their responsible use.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e76986"},"PeriodicalIF":2.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145471974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Risk Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study. 沙特阿拉伯三级中心2型糖尿病患者代谢功能障碍相关脂肪变性肝病患病率及危险因素:横断面问卷研究
IF 2.6 Q2 Medicine Pub Date : 2025-11-03 DOI: 10.2196/77772
Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh

Background: The escalating rates of obesity and type 2 diabetes mellitus (T2DM) in Saudi Arabia highlight the impending burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis.

Objective: This study aimed to identify MASLD among patients with T2DM at King Saud Medical City family medicine clinics, Riyadh, and explore associated factors to facilitate early intervention and prevention strategies.

Methods: This cross-sectional study identified patients with T2DM who attended King Saud Medical City, Riyadh, underwent an abdominal ultrasound, and were diagnosed with MASLD. The study data were collected by a peer-reviewed validated data extraction sheet and analyzed by SPSS (version 26.0; IBM Corp).

Results: Our study included 292 participants, with 47.3% (n=138) males and 52.7% (n=154) females. Notably, the prevalence of MASLD was 54.5% (n=159). Prevalent comorbidities included dyslipidemia (218/292, 74.7%) and hypertension (209/292, 71.6%). Most participants were nonsmokers (218/292, 74.7%). Higher waist circumference was significantly associated with MASLD (P=.02), with >80 cm among females (85/141, 60.3%) and >94 cm among males (60/141, 54.5%) affected across different stages of MASLD. Obesity (BMI>30 kg/m2) also significantly correlated with MASLD (P<.001). Individuals taking aspirin had half the odds of MASLD development (odds ratio [OR] 0.523, 95% CI 0.331-0.844; P=.007). Biochemical analysis revealed significant associations between MASLD and elevated alanine aminotransferase (P=.009), aspartate aminotransferase (P=.01), and homeostatic model assessment of insulin resistance (P=.001). Total cholesterol (P=.01), triglycerides (P=.03), and low-density lipoprotein (P=.04) were significantly elevated in patients with MASLD. Insulin exhibited a significant positive correlation with MASLD (r=0.24; P=.001). Glucose levels showed no significant association (r=0.03; P=.63).

Conclusions: Our study highlights significant associations between MASLD and various factors, including waist circumference, obesity, and certain biochemical markers. Furthermore, the protective effect of aspirin against MASLD warrants further investigation. These findings underscore the importance of early intervention and targeted preventive strategies.

背景:沙特阿拉伯肥胖和2型糖尿病(T2DM)发病率的上升凸显了代谢功能障碍相关的脂肪性肝病(MASLD)和非酒精性脂肪性肝炎迫在眉睫的负担。目的:本研究旨在确定利雅得沙特国王医疗城家庭医学诊所2型糖尿病患者的MASLD,并探讨相关因素,以促进早期干预和预防策略。方法:本横断面研究确定了在利雅得沙特国王医疗城就诊的T2DM患者,他们接受了腹部超声检查,并被诊断为MASLD。研究数据通过同行评审的有效数据提取表收集,并通过SPSS(26.0版本;IBM Corp)进行分析。结果:我们的研究纳入292名参与者,其中47.3% (n=138)男性,52.7% (n=154)女性。值得注意的是,MASLD的患病率为54.5% (n=159)。常见的合并症包括血脂异常(218/292,74.7%)和高血压(209/292,71.6%)。大多数参与者是非吸烟者(218/292,74.7%)。高腰围与MASLD显著相关(P= 0.02),在MASLD的不同阶段,女性的腰围为>80 cm(85/141, 60.3%),男性的腰围为>94 cm(60/141, 54.5%)。肥胖(BMI为30 kg/m2)与MASLD也显著相关(结论:我们的研究强调了MASLD与各种因素之间的显著相关性,包括腰围、肥胖和某些生化指标。此外,阿司匹林对MASLD的保护作用值得进一步研究。这些发现强调了早期干预和有针对性的预防策略的重要性。
{"title":"Prevalence and Risk Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study.","authors":"Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh","doi":"10.2196/77772","DOIUrl":"10.2196/77772","url":null,"abstract":"<p><strong>Background: </strong>The escalating rates of obesity and type 2 diabetes mellitus (T2DM) in Saudi Arabia highlight the impending burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis.</p><p><strong>Objective: </strong>This study aimed to identify MASLD among patients with T2DM at King Saud Medical City family medicine clinics, Riyadh, and explore associated factors to facilitate early intervention and prevention strategies.</p><p><strong>Methods: </strong>This cross-sectional study identified patients with T2DM who attended King Saud Medical City, Riyadh, underwent an abdominal ultrasound, and were diagnosed with MASLD. The study data were collected by a peer-reviewed validated data extraction sheet and analyzed by SPSS (version 26.0; IBM Corp).</p><p><strong>Results: </strong>Our study included 292 participants, with 47.3% (n=138) males and 52.7% (n=154) females. Notably, the prevalence of MASLD was 54.5% (n=159). Prevalent comorbidities included dyslipidemia (218/292, 74.7%) and hypertension (209/292, 71.6%). Most participants were nonsmokers (218/292, 74.7%). Higher waist circumference was significantly associated with MASLD (P=.02), with >80 cm among females (85/141, 60.3%) and >94 cm among males (60/141, 54.5%) affected across different stages of MASLD. Obesity (BMI>30 kg/m2) also significantly correlated with MASLD (P<.001). Individuals taking aspirin had half the odds of MASLD development (odds ratio [OR] 0.523, 95% CI 0.331-0.844; P=.007). Biochemical analysis revealed significant associations between MASLD and elevated alanine aminotransferase (P=.009), aspartate aminotransferase (P=.01), and homeostatic model assessment of insulin resistance (P=.001). Total cholesterol (P=.01), triglycerides (P=.03), and low-density lipoprotein (P=.04) were significantly elevated in patients with MASLD. Insulin exhibited a significant positive correlation with MASLD (r=0.24; P=.001). Glucose levels showed no significant association (r=0.03; P=.63).</p><p><strong>Conclusions: </strong>Our study highlights significant associations between MASLD and various factors, including waist circumference, obesity, and certain biochemical markers. Furthermore, the protective effect of aspirin against MASLD warrants further investigation. These findings underscore the importance of early intervention and targeted preventive strategies.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e77772"},"PeriodicalIF":2.6,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12582413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revolutionizing Hypoglycemia Management in Long-Term Care: Lessons Learned From a Pilot Quality Improvement Initiative Using Continuous Glucose Monitoring. 长期护理中革命性的低血糖管理:从使用连续血糖监测的试点质量改进计划中吸取的经验教训。
IF 2.6 Q2 Medicine Pub Date : 2025-10-20 DOI: 10.2196/73485
Denis O'Donnell, Sue Burns, Shirley Drever, Lisa Quesnelle, Benjamin Yuen
<p><strong>Unlabelled: </strong>Despite efforts to raise glycemic targets and reduce modifiable risk factors, hypoglycemia continues to impact a large number of long-term care (LTC) residents living with diabetes mellitus and remains one of the leading causes of hospitalization in this cohort. Effective, sustainable practice strategies to monitor and maintain glycemic control in LTC are lacking. We describe the stepwise approach used by 2 LTC homes that switched from traditional fingerstick testing to a continuous glucose monitoring (CGM) system as part of a quality improvement initiative to reduce nursing workload and address hypoglycemia. This was an exploratory pilot project. A working group was established at each of the 2 participating LTC homes, including representatives from management and direct care staff. Kickoff meetings were held with key direct care staff to discuss the limitations of current monitoring practices and potential solutions. The following interventions were agreed upon and implemented by the working groups: (1) the initiation of structured glucose monitoring for residents using CGM (FreeStyle Libre 2), requiring scanning of sensors 4 times per day; (2) provision of staff education and training on CGM by a diabetes expert; and (3) scheduling of interdisciplinary rounds as needed to optimize diabetes management. System changes were gradually introduced in a stepwise manner over a 3-month period (intervention phase), during which the LTC homes progressed from traditional fingerstick testing to point-of-care sensor readings and then to full use of the CGM software platform. Hypoglycemia was defined as a glucose reading of ≤4 mmol/L. Glucose readings were collected from 38 residents living with diabetes mellitus and receiving insulin in the 6 months before the start of the intervention phase (baseline evaluation) and in the 6 months after the end of the intervention phase (post-launch evaluation). All hypoglycemic readings detected by a sensor at a point-of-care test were validated using a fingerstick test. Nursing workload associated with glucose testing was assessed in an anonymous survey of nursing staff at baseline and after the launch. The approach resulted in a 40% reduction in nursing time required to complete a glucose reading (from 5.1 min per test at baseline to 3.1 min per test at the post-launch evaluation). The frequency of glucose monitoring increased from a total of 19,438 glucose readings in the baseline evaluation to 35,971 point-of-care sensor scans in the post-launch evaluation. The number of detected hypoglycemic events increased 12-fold, from 88 in the baseline evaluation to 1049 in the post-launch evaluation. Hypoglycemic events continue to impact a large number of LTC residents living with diabetes mellitus. CGM can improve the detection of hypoglycemic events while decreasing nursing workload. A gradual transition to CGM can help overcome underlying barriers and concerns and ensure a sustainable approa
未标记:尽管努力提高血糖目标并减少可改变的危险因素,但低血糖仍然影响着大量患有糖尿病的长期护理(LTC)居民,并且仍然是该队列中住院的主要原因之一。目前缺乏监测和维持LTC患者血糖控制的有效、可持续的实践策略。我们描述了两个LTC家庭使用的逐步方法,从传统的手指测试切换到连续血糖监测(CGM)系统,作为质量改进计划的一部分,以减少护理工作量并解决低血糖问题。这是一个探索性的试点项目。两间参与的长者养老服务院舍各成立了一个工作小组,包括管理人员和直接护理人员的代表。与主要的直接护理人员举行了启动会议,讨论当前监测实践的局限性和潜在的解决方案。工作组同意并实施了以下干预措施:(1)开始使用CGM (FreeStyle Libre 2)对居民进行结构化血糖监测,需要每天扫描传感器4次;(2)由糖尿病专家对员工进行CGM教育和培训;(3)根据需要安排跨学科查房,优化糖尿病管理。在3个月的时间里(干预阶段),逐步引入系统变更,在此期间,LTC家庭从传统的手指测试发展到护理点传感器读数,然后全面使用CGM软件平台。低血糖定义为血糖读数≤4 mmol/L。在干预阶段开始前6个月(基线评估)和干预阶段结束后6个月(启动后评估),收集38名接受胰岛素治疗的糖尿病患者的血糖读数。所有的低血糖读数由传感器检测到的点护理测试使用手指测试验证。护理工作量与血糖测试是在基线和启动后的护理人员的匿名调查进行评估。该方法使完成葡萄糖读数所需的护理时间减少了40%(从基线时的5.1分钟减少到启动后评估时的3.1分钟)。葡萄糖监测的频率从基线评估的19,438个葡萄糖读数增加到启动后评估的35,971个护理点传感器扫描。检测到的低血糖事件数量增加了12倍,从基线评估的88例增加到发射后评估的1049例。低血糖事件继续影响大量LTC居民与糖尿病。CGM可以提高低血糖事件的检出率,减少护理工作量。逐步过渡到CGM可以帮助克服潜在的障碍和关切,并确保可持续的做法。
{"title":"Revolutionizing Hypoglycemia Management in Long-Term Care: Lessons Learned From a Pilot Quality Improvement Initiative Using Continuous Glucose Monitoring.","authors":"Denis O'Donnell, Sue Burns, Shirley Drever, Lisa Quesnelle, Benjamin Yuen","doi":"10.2196/73485","DOIUrl":"10.2196/73485","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Unlabelled: &lt;/strong&gt;Despite efforts to raise glycemic targets and reduce modifiable risk factors, hypoglycemia continues to impact a large number of long-term care (LTC) residents living with diabetes mellitus and remains one of the leading causes of hospitalization in this cohort. Effective, sustainable practice strategies to monitor and maintain glycemic control in LTC are lacking. We describe the stepwise approach used by 2 LTC homes that switched from traditional fingerstick testing to a continuous glucose monitoring (CGM) system as part of a quality improvement initiative to reduce nursing workload and address hypoglycemia. This was an exploratory pilot project. A working group was established at each of the 2 participating LTC homes, including representatives from management and direct care staff. Kickoff meetings were held with key direct care staff to discuss the limitations of current monitoring practices and potential solutions. The following interventions were agreed upon and implemented by the working groups: (1) the initiation of structured glucose monitoring for residents using CGM (FreeStyle Libre 2), requiring scanning of sensors 4 times per day; (2) provision of staff education and training on CGM by a diabetes expert; and (3) scheduling of interdisciplinary rounds as needed to optimize diabetes management. System changes were gradually introduced in a stepwise manner over a 3-month period (intervention phase), during which the LTC homes progressed from traditional fingerstick testing to point-of-care sensor readings and then to full use of the CGM software platform. Hypoglycemia was defined as a glucose reading of ≤4 mmol/L. Glucose readings were collected from 38 residents living with diabetes mellitus and receiving insulin in the 6 months before the start of the intervention phase (baseline evaluation) and in the 6 months after the end of the intervention phase (post-launch evaluation). All hypoglycemic readings detected by a sensor at a point-of-care test were validated using a fingerstick test. Nursing workload associated with glucose testing was assessed in an anonymous survey of nursing staff at baseline and after the launch. The approach resulted in a 40% reduction in nursing time required to complete a glucose reading (from 5.1 min per test at baseline to 3.1 min per test at the post-launch evaluation). The frequency of glucose monitoring increased from a total of 19,438 glucose readings in the baseline evaluation to 35,971 point-of-care sensor scans in the post-launch evaluation. The number of detected hypoglycemic events increased 12-fold, from 88 in the baseline evaluation to 1049 in the post-launch evaluation. Hypoglycemic events continue to impact a large number of LTC residents living with diabetes mellitus. CGM can improve the detection of hypoglycemic events while decreasing nursing workload. A gradual transition to CGM can help overcome underlying barriers and concerns and ensure a sustainable approa","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e73485"},"PeriodicalIF":2.6,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145337905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1